Paul Clark

Paul N.
Clark currently works at Lilly ICOS LLC, as President & Chief Executive Officer and Grifols Therapeutics, Inc., as Director.
Mr. Clark also formerly worked at ICOS Corp., as Chairman, President & Chief Executive Officer from 2000 to 2007, Abbott Laboratories, as Director & Executive Vice President from 1984 to 1998, Amylin Pharmaceuticals, Inc., as Independent Director from 2011 to 2012, BIOLASE, Inc., as Director in 2017, Agilent Technologies, Inc., as Independent Director from 2006 to 2021, Agenus, Inc., as Independent Director from 2020 to 2021, Cerevast Medical, Inc., as Director, Keysight Technologies, Inc., as Lead Independent Non-Executive Director from 2019 to 2021, Talecris Biotherapeutics Holdings Corp., as Director, Catalent Pharma Solutions, Inc., as Director from 2007 to 2014, Harlan Laboratories, Inc., as Director from 2010 to 2014, Catalent, Inc., as Director, Genstar Capital Management LLC, as Operating Partner & Advisor, Marion Laboratories, as Vice President-Sales & Marketing in 1984, and Genstar Capital LLC, as Operating Partner from 2007 to 2013.
Mr. Clark received his undergraduate degree from The University of Alabama and Masters Business Admin degree from Tuck School of Business at Dartmouth.